Genetic Profiling for Risk Reduction in Human Cardiovascular Disease

Author： Puckelwartz Megan J.   McNally Elizabeth M.  

Publisher： MDPI

E-ISSN： 2073-4425|5|1|214-234

ISSN： 2073-4425

Source： Genes, Vol.5, Iss.1, 2014-03, pp. : 214-234

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Conversion in Human Genetic Disease

By Chen Jian-Min   Férec Claude   Cooper David N.  

Genes, Vol. 1, Iss. 3, 2010-12 ,pp. : 550-563

MDPI

Access to resources Recommend Favorite

The impact of multiplex genetic testing on disease risk perceptions

By  

CLINICAL GENETICS, Vol. 87, Iss. 2, 2015-02 ,pp. : 117-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic polymorphisms of serum amyloid A1 and coronary artery disease risk

By  

TISSUE ANTIGENS, Vol. 85, Iss. 3, 2015-03 ,pp. : 168-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Resveratrol metabolite profiling in clinical nutrition research—from diet to uncovering disease risk biomarkers: epidemiological evidence

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1348, Iss. 1, 2015-08 ,pp. : 107-115

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Effect of Dietary Supplementation of Green Tea Catechins on Cardiovascular Disease Risk Markers in Humans: A Systematic Review of Clinical Trials

By Lau Sarah O.   Georgousopoulou Ekavi N.   Kellett Jane   Thomas Jackson   McKune Andrew   Mellor Duane   Roach Paul D.   Naumovski Nenad  

Beverages, Vol. 2, Iss. 2, 2016-06 ,pp. : 16-16

MDPI

Access to resources Recommend Favorite